Search

Author/Creator Deodhar, Mandar

1. An activity‐based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti‐fibrotic therapeutic strategies. Issue 11 (6th November 2021)

Authors:
Findlay, Alison; Turner, Craig; Schilter, Heidi; Deodhar, Mandar; Zhou, Wenbin; Perryman, Lara; Foot, Jonathan; Zahoor, Amna; Yao, Yimin; Hamilton, Ross; Brock, Mary; Raso, Christina; Stolp, Jessica; Galati, Marie; Hamprecht, Dieter; Charlton, Brett; Jarolimek, Wolfgang
Journal:
Clinical and translational medicine
Issue:
Volume 11:Issue 11(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Combining monoamine oxidase B and semicarbazide-sensitive amine oxidase enzyme inhibition to address inflammatory disease. (15th October 2022)

Authors:
Foot, Jonathan S.; Buson, Alberto; Deodhar, Mandar; Findlay, Alison D.; Robertson, Alan D.; Turner, Craig I.; Yow, Tin; Zhou, Wenbin; Jarolimek, Wolfgang
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 74(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The lysyl oxidase like 2/3 enzymatic inhibitor, PXS‐5153A, reduces crosslinks and ameliorates fibrosis. Issue 3 (9th December 2018)

Authors:
Schilter, Heidi; Findlay, Alison D.; Perryman, Lara; Yow, Tin T.; Moses, Joshua; Zahoor, Amna; Turner, Craig I.; Deodhar, Mandar; Foot, Jonathan S.; Zhou, Wenbin; Greco, Angelique; Joshi, Amar; Rayner, Benjamin; Townsend, Sarah; Buson, Alberto; Jarolimek, Wolfgang
Journal:
Journal of cellular and molecular medicine
Issue:
Volume 23:Issue 3(2019)
Page Start:
1759
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗